500
Views
24
CrossRef citations to date
0
Altmetric
Review

Emerging cardiometabolic complications of androgen deprivation therapy

&
Pages 1-9 | Received 02 Sep 2009, Accepted 12 Oct 2009, Published online: 12 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, Giovanni Corona, Stefan Arver, Svetlana Kalinchenko, Yuliya Tishova & Abraham Morgentaler. (2021) Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men. The Aging Male 24:1, pages 119-138.
Read now
Marius Kincius, Ausvydas Patasius, Donata Linkeviciute-Ulinskiene, Lina Zabuliene & Giedre Smailyte. (2020) Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients. The Aging Male 23:5, pages 1333-1338.
Read now
Daisuke Watanabe, Takahiro Kimura, Akemi Yamashita, Tadaaki Minowa, Kunihisa Miura & Akio Mizushima. (2020) The influence of androgen deprivation therapy on hip geometric properties and bone mineral density in Japanese men with prostate cancer and its relationship with the visceral fat accumulation. The Aging Male 23:5, pages 1158-1164.
Read now
Yasin Ceylan, Bulent Gunlusoy, Asli Koskderelioglu, Muhtesem Gedizlioglu & Tansu Degirmenci. (2020) The depressive effects of androgen deprivation therapy in locally advanced or metastatic prostate cancer: a comparative study. The Aging Male 23:5, pages 733-739.
Read now
Paolo Sgrò, Massimiliano Sansone, Andrea Sansone, Stefania Sabatini, Paolo Borrione, Francesco Romanelli & Luigi Di Luigi. (2019) Physical exercise, nutrition and hormones: three pillars to fight sarcopenia. The Aging Male 22:2, pages 75-88.
Read now
Kristina Groti, Ivan Žuran, Blaž Antonič, Lidija Foršnarič & Marija Pfeifer. (2018) The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. The Aging Male 21:3, pages 158-169.
Read now
Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, Stefan Arver, Svetlana Kalinchenko, Yuliya Tishova & Abraham Morgentaler. (2015) Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. The Aging Male 18:1, pages 5-15.
Read now
Bruno Lunenfeld, George Mskhalaya, Svetlana Kalinchenko & Yulia Tishova. (2013) Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men – a suggested update. The Aging Male 16:4, pages 143-150.
Read now
Brandon Chock, Tzu-Chun Lin, Chin-Shang Li & Arthur Swislocki. (2012) Plasma testosterone is associated with Framingham risk score. The Aging Male 15:3, pages 134-139.
Read now

Articles from other publishers (14)

Matthew Alberto, Arthur Yim, Nathan Lawrentschuk & Damien Bolton. (2023) Dysfunctional Lipid Metabolism—The Basis for How Genetic Abnormalities Express the Phenotype of Aggressive Prostate Cancer. Cancers 15:2, pages 341.
Crossref
Natalie K. Vear, Jeff S. Coombes, Tom G. Bailey & Tina L. Skinner. (2020) The Interplay between Vascular Function and Sexual Health in Prostate Cancer: The Potential Benefits of Exercise Training. Medical Sciences 8:1, pages 11.
Crossref
Daniel M. Lim, Roman Gulati, Serge Aleshin-Guendel, Agnes Gawne, Jonathan T. Wingate, Heather H. Cheng, Ruth Etzioni & Evan Y. Yu. (2018) Undetectable prostate-specific antigen after short-course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis-free survival and prostate cancer-specific survival. The Prostate 78:14, pages 1077-1083.
Crossref
Fiona Crawford-Williams, Sonja March, Belinda C. Goodwin, Nicholas Ralph, Daniel A. Galvão, Robert U. Newton, Suzanne K. Chambers & Jeff Dunn. (2018) Interventions for prostate cancer survivorship: A systematic review of reviews. Psycho-Oncology 27:10, pages 2339-2348.
Crossref
Tobias Engel Ayer Botrel, Otávio Clark, Rodolfo Borges dos Reis, Antônio Carlos Lima Pompeo, Ubirajara Ferreira, Marcus Vinicius Sadi & Francisco Flávio Horta Bretas. (2014) Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis. BMC Urology 14:1.
Crossref
Ted A. Skolarus, Andrew M.D. Wolf, Nicole L. Erb, Durado D. Brooks, Brian M. Rivers, Willie UnderwoodIIIIII, Andrew L. Salner, Michael J. Zelefsky, Jeanny B. Aragon-Ching, Susan F. Slovin, Daniela A. Wittmann, Michael A. Hoyt, Victoria J. Sinibaldi, Gerald Chodak, Mandi L. Pratt-Chapman & Rebecca L. Cowens-Alvarado. (2014) American Cancer Society prostate cancer survivorship care guidelines. CA: A Cancer Journal for Clinicians 64:4, pages 225-249.
Crossref
Joanne M. Harrington, Dawn C. Schwenke, Dana R. Epstein & Donald E. Bailey. (2014) Androgen-Deprivation Therapy and Metabolic Syndrome in Men With Prostate Cancer. Oncology Nursing Forum 41:1, pages 21-29.
Crossref
David Pereg, Justin Chan, Evan Russell, Tatiana Berlin, Morris Mosseri, Jamie A. Seabrook, Gideon Koren & Stan Van Uum. (2013) Cortisol and testosterone in hair as biological markers of systolic heart failure. Psychoneuroendocrinology 38:12, pages 2875-2882.
Crossref
Noboru Hara, Fumio Ishizaki, Toshihiro Saito, Tsutomu Nishiyama, Takashi Kawasaki & Kota Takahashi. (2013) Decrease in Lean Body Mass in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: Mechanism and Biomarkers. Urology 81:2, pages 376-380.
Crossref
Jenny Ma, Patrick V. Granton, David W. Holdsworth & Eva A. Turley. (2013) Oral Administration of Hyaluronan Reduces Bone Turnover in Ovariectomized Rats. Journal of Agricultural and Food Chemistry 61:2, pages 339-345.
Crossref
Akl C. Fahed, Joanna M. Gholmieh & Sami T. Azar. (2012) Connecting the Lines between Hypogonadism and Atherosclerosis. International Journal of Endocrinology 2012, pages 1-12.
Crossref
. (2011) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 18:3, pages 231-234.
Crossref
. (2011) Current World Literature. Current Opinion in Urology 21:3, pages 257-264.
Crossref
George Yu & Abdulmaged M. Traish. (2011) Induced testosterone deficiency: from clinical presentation of fatigue, erectile dysfunction and muscle atrophy to insulin resistance and diabetes. Hormone Molecular Biology and Clinical Investigation 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.